Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.
Apomine, a novel 1,1 bisphosphonate ester, increases the rate of degradation of HMG-CoA reductase, inhibiting the mevalonate pathway and thereby blocking cholesterol biosynthesis. We have investigated whether Apomine can induce myeloma cell apoptosis in vitro and modulate myeloma disease in vivo. Ap...
Үндсэн зохиолчид: | Edwards, C, Mueller, G, Roelofs, A, Chantry, A, Perry, M, Russell, R, Van Camp, B, Guyon-Gellin, Y, Niesor, E, Bentzen, C, Vanderkerken, K, Croucher, P |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2007
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Apomine, an inhibitor of HMG-COA-reductase, does not act by inhibiting protein prenylation in human myeloma cells in vitro
-н: Roelofs, A, зэрэг
Хэвлэсэн: (2005) -
APOMINE (TM), a novel inhibitor of the meyalonate/isoprenoid pathway, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of the myeloma disease in vivo.
-н: Croucher, P, зэрэг
Хэвлэсэн: (2002) -
Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
-н: Roelofs, A, зэрэг
Хэвлэсэн: (2007) -
Novel insights into the anti-tumour mechanism of action of apomine and its synergistic interaction with lovastatin in myeloma cells in vitro
-н: Roelofs, A, зэрэг
Хэвлэсэн: (2006) -
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
-н: Croucher, P, зэрэг
Хэвлэсэн: (2003)